Abstract
We have established a new xenogeneic animal model of leptomeningeal metastasis (LM) by intracisternal inoculation of human CEM T-cell lymphoma into nude rats, and used it to evaluate the anti-lymphoma efficacy of an anti-CD7 ricin A chain immunotoxin (DA7). In vitro incubation with 2 μg/ml DA7 for 72 h inhibited CEM cells by 90% in a trypan blue exclusion assay. To establish its anti-lymphoma activity, one and four days after cisternal inoculation of 106 CEM cells, eight animals each were treated cisternally with 10 μg DA7 in 50 μl PBS or sham-treated with 50 μl PBS. Histopathologically, all eight sham-treated and five of eight DA7 treated animals showed typical features of LM with multilayers of tumor cells along the whole subarachnoid space and the ventricular walls, as well as subependymal and diffuse parenchymal tumor cell infiltration. Three DA7 treated animals were free of tumor. Two of these animals were asymptomatic long-term survivors (> 90 days). The third tumor-free animal suddenly died on day 51. Histology revealed viral myocarditis. Median symptom-free survival was 51 days (range 29–90+ days) in DA7 treated and 34 days (range 29–87 days) in sham-treated animals (p=0.12, log-rank test). Histologically, no signs of neurotoxicity or systemic toxicity was found. However, DA7 treated animals showed a tendency to a slower weight increase on days 6–28 after tumor cell inoculation. Our results indicate that this model is useful in studying leptomeningeal seeding and intracisternal treatment of lymphoma. The demonstrated anti-tumor effect of DA7 treatment deserves further evaluation especially regarding the application of DA7 in early stages of LM from T-cell lymphoma.
Similar content being viewed by others
References
Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: a clinical and pathologic study. Arch Neurol 30: 122-137, 1974
Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors. Cancer 49: 759-722, 1982
Piukel D, Woo S: Prevention and treatment of meningeal leukemia in children. Blood 84: 355-366, 1994
Steinherz PG: CNS leukemia: Problem of diagnosis, treatment, and outcome. J Clin Oncol 13: 310-313, 1995
LoBuglio AF, Salch MN: Monoclonal antibody therapy of cancer. Crir Rev Oncol/Hematol 13: 271-282, 1992
Vallera DA: Immunotoxins: will their clinical promise be fulfulled? Blood 83: 309-317, 1994
Hertler AW, Schlossman DM, Borowitz MJ, Poplack DG, Frankel AE: An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother 28: 59-66, 1989
Schabet M, Wiethölter H, Meier D: Experimental meningeal neoplasia in nude rats. Neurology 37: 311, 1989 (Abstract)
Myklebust AT, Godal A, Fodstad O: Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer. Cancer Res 54: 2146-2150, 1994
Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herdon J, Bigner DD: Intrathecal administration of single-chain immunotoxin, LMB-7 (B3(Fv)-PE38), produces cures of carcinomatous meningitis in a rat model. Proc Natl Acad Sci USA 92: 2765-2769, 1995
Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad Ö: In vivo efficacy of intrathecal transferrin-pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery 34: 649-656, 1994
Zovickian J, Youle RJ: Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasia. J Neurosurg 68: 767-774, 1988
Urch CE, George AJT, Stevenson GT, Bolognesi A, Stirpe F, Weller R, Glennie MJ: Intrathecal treatment of leptomeningeal lymphoma with immunotoxin. Int J Cancer 47: 909-915, 1991
Walbridge S, Rybak SM: Immunotoxin therapy of leptomeningeal neoplasia. J Neuro-Oncol 20: 59-65, 1994
Fulton RJ, Blakey DC, Knowles PP, Uhr JW, Thorpe PE, Vitetta ES: Purification of ricin A1, A2 and B chains and characterization of their toxicity. J Biol Chem 261: 5314-5319, 1986
Jansen B, Vallera DA, Jaszcz WB, Nguyen D, Kersey JH: Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA 7. Cancer Res 52: 1314-1321, 1992
Thorpe PE, Detre SI, Foxwell BMJ, Brown ANF, Skilleter DN, Wilson G, Forrester JA, Stirpe F: Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Eur J Biochem 147: 197-206, 1985
Stong RC, Youle RJ, Vallera DA: Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Cancer Res 44: 3000-3006, 1984
Alley MC, Scudeiro DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasability of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988
Schabet M, Ohnseseit P, Buchholz R, Santo-Hoeltje L, Schmidberger H: Intrathecal ACNU treatment of B16 melanoma lcptomeningeal metastasis. J Neuro-Oncol 14: 169-175, 1992
Poplaek DG, Magrath IT, Kun EK, Pizzo PA: Leukemias and lymphomas of childhood. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles & Practice of Oncology. 4th Edition. J.B. Lippincott, Philadelphia 1792-1818, 1993
Preijers FWMB, De Witte T, Rijke-Schilder GPM, Tax WJM, Wessels JMC, Haanen C, Capel PJA: Human T lymphocyte antigens as target for immunotoxins or complement-mediated cytotoxicity. Scand J Immunol 28: 185-194, 1988
Mann JD, Butler AB, Johnson RN, Bass NH: Clearance of macromolecular and particulate substances from the cerebrospinal fluid system of the rat. J Neurosurg 50: 343-348, 1979
Preijers FWMB, Tax WJM, DeWitte T, Janssen A, Van der Heijden H, Vidal H, Wessels JMC, Capel PJA: Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins. Brit J Haematol 70: 289-294, 1988
Laurent G, Kuhlein E, Casellas P, Canat X, Carayon P, Poncelet P, Correll S, Rigal F, Jansen FK: Determination of sensitivity of fresh leukemia cells to immunotoxins. Cancer Res 46: 2289-2294, 1986
Riedel CJ, Muraszko KM, Youle RJ: Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons. Proc Natl Acad Sci USA 87: 5051-5055, 1990
Muraszko K, Sung C, Walbridge S, Greenfield L, Dedrick RL, Oldfield EH, Youle RJ: Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Cancer Res 53: 3752-3757, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herrlinger, U., Schmidberger, H., Buchholz, R. et al. Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin. J Neurooncol 40, 1–9 (1998). https://doi.org/10.1023/A:1005815503950
Issue Date:
DOI: https://doi.org/10.1023/A:1005815503950